Tumor-infiltrating lymphocytes in breast cancer: A new predictor for responses to therapy

Tumor-infiltrating lymphocytes in breast cancer: A new predictor for responses to therapy

We have prospectively validated in an independent clinical cohort the finding that elevated amounts of tumor-infiltrating lymphocytes in breast carcinoma tissues predict the response of patients to neoadjuvant chemotherapy. These results suggest that a robust tumor infiltration by T and B cells is a...

Full description

Bibliographic Details
Main Authors:	Issa-Nummer, Yasmin, Loibl, Sibylle, von Minckwitz, Gunter, Denkert, Carsten
Format:	Online
Language:	English
Published:	Landes Bioscience 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203634/

Similar Items

Prospective Validation of Immunological Infiltrate for Prediction of Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer – A Substudy of the Neoadjuvant GeparQuinto Trial
by: Issa-Nummer, Yasmin, et al.
Published: (2013)

State of the art in neoadjuvant therapy of breast cancer
by: Minckwitz, Gunter von, et al.
Published: (2013)

Relevance of tumor-infiltrating lymphocytes in breast cancer
by: Dushyanthen, Sathana, et al.
Published: (2015)

Clinical significance of tumor-infiltrating lymphocytes in breast cancer
by: Stanton, Sasha E., et al.
Published: (2016)

Characterization and quantification of tumor infiltrating lymphocytes in breast cancer
by: Bedri, Shahinaz, et al.
Published: (2014)

HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer
by: Denkert, Carsten, et al.
Published: (2013)

Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis
by: Loibl, Sibylle, et al.
Published: (2011)

Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer
by: Darb-Esfahani, S, et al.
Published: (2012)

Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy – the SpheroNEO study
by: Halfter, Kathrin, et al.
Published: (2015)

Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques
by: Heil, Joerg, et al.
Published: (2015)

Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes
by: Darb-Esfahani, Silvia, et al.
Published: (2014)

Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast
by: Toss, Michael S., et al.
Published: (2018)

Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy
by: Loi, Sherene
Published: (2013)

Evaluation of the prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers
by: Tian, Tian, et al.
Published: (2016)

Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer
by: Mani, Nikita L., et al.
Published: (2016)

Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting
by: García-Teijido, Paula, et al.
Published: (2016)

Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
by: Castaneda, Carlos A, et al.
Published: (2016)

Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer
by: Ahn, Sung Gwe, et al.
Published: (2015)

Ways to Enhance Lymphocyte Trafficking into Tumors and Fitness of Tumor Infiltrating Lymphocytes
by: Bellone, Matteo, et al.
Published: (2013)

Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy
by: Kodumudi, Krithika N., et al.
Published: (2016)

Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma
by: Sarnaik, Amod, et al.
Published: (2015)

Preclinical development of tumor-infiltrating lymphocyte therapy for ovarian cancer
by: Sakellariou-Thompson, Donastas, et al.
Published: (2015)

Generation of tumor-infiltrating lymphocytes from pancreatic cancer lesions for cellular therapy
by: Meng, Qingda, et al.
Published: (2014)

Identification of predictive biomarker signatures in melanoma tumors associated with response to tumor-infiltrating lymphocyte (TIL) therapy
by: Chen, Jie Qing, et al.
Published: (2013)

Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery
by: Denkert, Carsten, et al.
Published: (2012)

The antigen specific composition of melanoma tumor infiltrating lymphocytes?
by: Hadrup, Sine Reker
Published: (2012)

Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
by: Fortes, Cristina, et al.
Published: (2015)

Marrow-Infiltrating Lymphocytes – Role in Biology and Cancer Therapy
by: Borrello, Ivan, et al.
Published: (2016)

Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer
by: West, Nathan R, et al.
Published: (2011)

Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers
by: Miao Ruan, et al.
Published: (2018-08-01)

Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: A meta-analysis
by: Wang, Ke, et al.
Published: (2016)

The Value of Tumor Infiltrating Lymphocytes (TILs) for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
by: Mao, Yan, et al.
Published: (2014)

PD-L1 expression and tumor-infiltrating lymphocytes: Revisiting the antitumor immune response potential in breast cancer
by: Schalper, Kurt A
Published: (2014)

Tumor Infiltrating Lymphocytes – The Next Step in Assessing Outcome and Response to Treatment in Patients with Breast Cancer
by: Wesolowski, Robert, et al.
Published: (2014)

CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast
by: Rathore, Ankita Singh, et al.
Published: (2014)

Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
by: Seo, A N, et al.
Published: (2013)

Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
by: Hall, MacLean, et al.
Published: (2016)

Identification of tumor-specific T cell receptors from primary tumor-infiltrating lymphocytes
by: Kishi, Hiroyuki, et al.
Published: (2015)

Classical pathology and mutational load of breast cancer – integration of two worlds
by: Budczies, Jan, et al.
Published: (2015)

Tumor-Infiltrating Lymphocytes and Breast Cancer: Are Immune Checkpoint Inhibitors Ready for Prime Time in Breast Cancer?
by: Cvetanović Ana, et al.
Published: (2016-12-01)